A Multi-Center, Double Dummy, Comparing Efficacy and Safety of Valsartan/Amlodipine 80/5mg to Amlodipine 5mg Alone Once Daily in Patients With Mild to Moderate Essential Hypertension Not Adequately Controlled With Amlodipine 5mg Monotherapy.
Phase of Trial: Phase III
Latest Information Update: 23 Apr 2013
At a glance
- Drugs Amlodipine/valsartan (Primary) ; Amlodipine
- Indications Essential hypertension; Hypertension
- Focus Therapeutic Use
- Sponsors Novartis
- 16 Jun 2010 Results have been presented at the 17th World Congress of Cardiology.
- 14 May 2010 Results published in Current Medical Research and Opinion.
- 28 Oct 2008 Novartis Pharmaceuticals added as trial affiliate as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History